Prognostic immune markers for recurrence and survival in locally advanced esophageal adenocarcinoma.

Authors

null

Laila Babar

The Esophageal and Lung Institute, Allegheny Health Network, Pittsburgh, PA

Laila Babar , Ali Hussainy Zaidi , Ashten N. Omstead , Ping Zheng , Ronan Joseph Kelly , Blair Anderson Jobe

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach

Track

Cancers of the Esophagus and Stomach

Sub Track

Translational Research

Citation

J Clin Oncol 37, 2019 (suppl 4; abstr 50)

DOI

10.1200/JCO.2019.37.4_suppl.50

Abstract #

50

Poster Bd #

F20

Abstract Disclosures

Similar Posters

Poster

2020 ASCO Virtual Scientific Program

A novel gene signature for predicting response to chemoradiotherapy in locally advanced esophageal adenocarcinoma.

A novel gene signature for predicting response to chemoradiotherapy in locally advanced esophageal adenocarcinoma.

First Author: Divya Sahu

Poster

2019 Gastrointestinal Cancers Symposium

Biomarkers of immunotherapy response in rectal adenocarcinoma treated with neoadjuvant chemoradiotherapy.

Biomarkers of immunotherapy response in rectal adenocarcinoma treated with neoadjuvant chemoradiotherapy.

First Author: Gurveen Kaur

First Author: Hirotaka Miyashita

First Author: Niki Gavrielatou